The impact of pharmaceutical action in improving the quality of life of patients with type II diabetes mellitus: an integrative review

Authors

DOI:

https://doi.org/10.33448/rsd-v12i1.39552

Keywords:

Type 2 diabetes mellitus; Pharmaceutical care; ; Glycemic control.

Abstract

Diabetes mellitus is an endocrine-metabolic disease. Patients have high levels of glucose in the blood or hyperglycemia, with a deficient secretion of insulin or a decrease in the action of insulin in the body. Can be caused by the absolute absence of insulin, identified by Diabetes Mellitus type 1 (DM-1) or insulin-dependent, or by insufficient insulin secretion by the pancreas and/or resistance to its action, characterizing Type 2 Diabetes Mellitus (DM-2). The objective of the study was to verify, in previously published works, how the presence of a pharmacist can be important in the treatment and improvement of the quality of life of patients with DM-2. The article was qualitative research of integrative bibliographic review, where the theme was identified, the selection of the research question establishing the inclusion and exclusion criteria. Eleven articles were selected for the study based on the descriptors in Portuguese in the combinations: “pharmaceutical care” and “type 2 diabetes mellitus” and “pharmaceutical care” and “type 2 diabetes mellitus” and “glycemic control” in the SciELO, BVS and Science Direct in Portuguese, English and Spanish over a period of 5 years. It was concluded that the pharmaceutical professional is essential for the health of patients with DM, promoting a reduction in HbA1c levels, a decrease in blood pressure, improvement in triglycerides and greater adherence to drug treatment and economy. Pharmaceutical monitoring in person and by telephone contributed to greater adherence to treatment and improved health as a whole.

References

Almaguer Herrera, A., Miguel Soca, P., Reynaldo Será, C., Mariño Soler, A., & Oliveros Guerra, R. (2012). Actualización sobre diabetes mellitus. Correo Científico Médico, 16(2.ed.). http://revcocmed.sld.cu/index.php/cocmed/article/view/507

Alves, N. R., Menezes, P. D. L. de, Diniz, J. A., Souza, F. A. F. de, Carvalho, P. M. de M., & Tavares, S. M. Q. M. C. (2019). Avaliação das interações medicamentosas entre antihipertensivos e hipoglicemiantes orais / Evaluation of drug interactions between antihypertensive and oral hypoglycemic agents. ID on Line. Revista de Psicologia, 13(44.ed), 374–392. https://doi.org/10.14295/idonline.v13i44.1625

Benedict, A. W., Spence, M. M., Sie, J. L., Chin, H. A., Ngo, C. D., Salmingo, J. F., Vidaurreta, A. T., & Rashid, N. (2018). Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System. Journal of Managed Care &Amp, Specialty Pharmacy, 24(2.ed.), 114–122. https://doi.org/10.18553/jmcp.2018.24.2.114

Brentegani, K. R. (2017). A importância da atenção farmacêutica para portadores de diabetes mellitus tipo II em drogarias. Trabalho de Conclusão de Curso, Bacharelado em Farmácia, Universidade Federal de Mato Grosso. Mato Grosso, Brasil. https://bdm.ufmt.br/handle/1/1317

Borges, D. de B., & Lacerda, J. T. de. (2018). Ações voltadas ao controle do Diabetes Mellitus na Atenção Básica: proposta de modelo avaliativo. Saúde Em Debate, 42(116.ed.), 162–178. https://doi.org/10.1590/0103-1104201811613

Botelho, L. L. R., Cunha, C. C. D. A., & Macedo, M. (2011). O método da revisão integrativa nos estudos organizacionais. Gestão E Sociedade, 5(11.ed.), 121. https://doi.org/10.21171/ges.v5i11.1220

Carvalho, C., Rocha, L., Carvalho, D., Silva, B., Oliveira, S., & Silveira, R. (2017). Adesão de pessoas com diabetes mellitus tipo II ao tratamento medicamentoso. Revista de Enfermagem UFPE on line, 11(9.ed.), 3402-3409. https://doi.org/10.5205/1981-8963-v11i9a110239p3402-3409-2017

Cowart, K., Updike, W., Emechebe, N., & Zgibor, J. (2020). Using an Advanced Practice Pharmacist in a Team-Based Care Model to Decrease Time to Hemoglobin A1c Goal Among Patients With Type 2 Diabetes, Florida, 2017-2019. Preventing chronic disease, 17, E40. https://doi.org/10.5888/pcd17.190377

Guidoni, C. M., Olivera, C. M. X., Freitas, O. D., & Pereira, L. R. L. (2009). Assistência ao diabetes no Sistema Único de Saúde: análise do modelo atual. Brazilian Journal of Pharmaceutical Sciences, 45, 37–48. https://doi.org/10.1590/s1984-82502009000100005

Hirsch, J. D., Bounthavong, M., Arjmand, A., Ha, D. R., Cadiz, C. L., Zimmerman, A., Ourth, H., Morreale, A. P., Edelman, S. V., & Morello, C. M. (2017). Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management “Tune-Up” Clinic. Journal of Managed Care &Amp, Specialty Pharmacy, 23(3.ed.), 318–326. https://doi.org/10.18553/jmcp.2017.23.3.318

International Diabetes Federation. IDF diabetes atlas. (10.ed.). International Diabetes Federation, 2021. https://diabetesatlas.org/atlas/tenth-edition/?dlmodal=active&dlsrc=https%3A%2F%2Fdiabetesatlas.org%2Fidfawp%2Fresource-files%2F2021%2F07%2FIDF_Atlas_10th_Edition_2021.pdf

Javaid, Z., Imtiaz, U., Khalid, I., Saeed, H., Khan, R. Q., Islam, M., Saleem, Z., Sohail, M. F., Danish, Z., Batool, F., & Anwer, N. (2019). A randomized control trial of primary care-based management of type 2 diabetes by a pharmacist in Pakistan. BMC Health Services Research, 19(1.ed.). https://doi.org/10.1186/s12913-019-4274-z

Korcegez, E. I., Sancar, M., & Demirkan, K. (2017). Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial. Journal of Managed Care &Amp, Specialty Pharmacy, 23(5.ed.), 573–582. https://doi.org/10.18553/jmcp.2017.23.5.573

Lopes, V. P., Dos santos Júnior, M. C., Santos Júnior, A. D. F., & Costa Santana, A. I. (2012). Farmacologia do diabetes mellitus tipo 2: antidiabéticos orais, insulina e inovações terapêuticas. Revista Eletrônica De Farmácia, 9(4.ed.). https://doi.org/10.5216/ref.v9i4.18918

Melo, R. C. de, Araújo, B. C. de, Luquine Júnior, C. D., Milhomens, L. de M., Silva, L. A. L. B. da, Bortoli, M. C. de, Toma, T. S., & Barreto, J. O. M. (2021). Estratégias de adesão ao tratamento de longo prazo para pessoas adultas com diabetes mellitus tipo 2 na APS. Fiocruz, Brasilia, DF, Instituto de Saúde de São Paulo, São Paulo, SP, 1–19. https://docs.bvsalud.org/biblioref/2022/02/1358445/08_sre_depros_dm_adesao.pdf

Nogueira, M., Otuyama, L. J., Rocha, P. A., & Pinto, V. B. (2020). Pharmaceutical care-based interventions in type 2 diabetes mellitus : a systematic review and meta-analysis of randomized clinical trials. Einstein (São Paulo), 18. https://doi.org/10.31744/einstein_journal/2020rw4686

Pereira, P. D. F., Santos, J. C. D., Cortez, D. N., Reis, I. A., & Torres, H. D. C. (2021). Avaliação das estratégias de educação em grupo e intervenção telefônica para o diabetes tipo 2. Revista Da Escola De Enfermagem Da USP, 55. https://doi.org/10.1590/s1980-220x2020002603746

Pereira, L. B., Guidoni, C. M., Borges, A. P. D. S., & Pereira, L. R. L. (2018). Avaliação da efetividade do acompanhamento farmacoterapêutico no controle do diabetes mellitus tipo 2 em longo prazo. Clinical &Amp, Biomedical Research, 38(3.ed.), 237–244. https://doi.org/10.4322/2357-9730.81089

Picoli, R. M. (2015). Análise de custo efetividade da atenção farmacêutica no tratamento do diabetes mellitus tipo 2. Dissertação de Mestrado em Administração de Organizações, Faculdade de Economia, Administração e Contabilidade de Ribeirão Preto, Universidade de São Paulo. Ribeirão Preto, Brasil. https://www.teses.usp.br/teses/disponiveis/96/96132/tde-02092015- 100832/en.php

Pompeo, D. A., Rossi, L. A., & Galvão, C. M. (2009). Revisão integrativa: etapa inicial do processo de validação de diagnóstico de enfermagem. Acta Paulista De Enfermagem, 22(4.ed.), 434–438. https://doi.org/10.1590/s0103-21002009000400014

Qualis periódicos. Plataforma Sucupira. Versão 3.63.0 . 2022. https://sucupira.capes.gov.br/sucupira/

Repolho, K. T. F. (2019). Atuação do Farmacêutico com Impacto no Acompanhamento Farmacoterapêutico aos pacientes portadores de Diabetes Mellitus Tipo 2: uma revisão sistemática. Trabalho de Conclusão de Curso, Bacharelado em Farmácia, Universidade Federal do Amazonas. Itacoatiara, Brasil.

http://riu.ufam.edu.br/handle/prefix/5639

Ribeiro, L. C. (2020). A importância do cuidado farmacêutico na prevenção e tratamento de doenças cardiovasculares. Revista Eletrônica Acervo Saúde, (57), e4058-e4058.

Wu, W. C., Taveira, T. H., Jeffery, S., Jiang, L., Tokuda, L., Musial, J., Cohen, L. B., & Uhrle, F. (2018). Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial. PLOS ONE, 13(4.ed.), e0195898. https://doi.org/10.1371/journal.pone.0195898

Published

08/01/2023

How to Cite

SOUSA, D. .; ALMEIDA, L. F. de .; RIBEIRO, L. M. S. .; ANDRADE, A. W. L. . The impact of pharmaceutical action in improving the quality of life of patients with type II diabetes mellitus: an integrative review. Research, Society and Development, [S. l.], v. 12, n. 1, p. e20012139552, 2023. DOI: 10.33448/rsd-v12i1.39552. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/39552. Acesso em: 20 apr. 2024.

Issue

Section

Health Sciences